Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes (Abstract in rivista)

Type
Label
  • Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes (Abstract in rivista) (literal)
Anno
  • 2013-01-01T00:00:00+01:00 (literal)
Alternative label
  • Ferrannini, E.;Muscelli, E.;Frascerra, S.;Baldi, S.;Mari, A.;Heise, T.;Broedl, U.C.;Woerle, H.-J. (2013)
    Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Ferrannini, E.;Muscelli, E.;Frascerra, S.;Baldi, S.;Mari, A.;Heise, T.;Broedl, U.C.;Woerle, H.-J. (literal)
Pagina inizio
  • S392 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 56 (literal)
Rivista
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
  • S1 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • 1 - 4: Department of Internal Medicine, University of Pisa; 5: CNR Institute of Biomedical Engineering, Padova, Italy; 6: Profil Institute, Neuss; 7, 8: Boeringher Ingelheim, Germany (literal)
Titolo
  • Metabolic response to sodium-glucose transporter 2 (SGLT2) inhibition with empagliflozin in patients with type 2 diabetes (literal)
Prodotto di
Autore CNR

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it